BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12629110)

  • 1. Validation and calibration of the Kabi Pharmacia International Growth Study prediction model for children with idiopathic growth hormone deficiency.
    de Ridder MA; Stijnen T; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1223-7. PubMed ID: 12629110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
    Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1174-83. PubMed ID: 10199749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study.
    Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA;
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4212-8. PubMed ID: 11095456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a calibrated prediction model for response to growth hormone treatment in an independent cohort.
    de Ridder MA; Stijnen T; Drop SL; Blum WF; Hokken-Koelega AC
    Horm Res; 2006; 66(1):13-6. PubMed ID: 16675910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of overweight on effectiveness of treatment with human growth hormone in growth hormone deficient children: analysis of German KIGS data.
    Reinehr T; Bechtold-Dalla Pozza S; Bettendorf M; Doerr HG; Gohlke B; Hauffa BP; Kaspers S; Land C; Mehls O; Schwab KO; Stahnke N; Ranke MB;
    Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):544-8. PubMed ID: 22006181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the response to recombinant human growth hormone in Turner syndrome: KIGS models. KIGS International Board. Kabi International Growth Study.
    Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA
    Acta Paediatr Suppl; 1999 Dec; 88(433):122-5. PubMed ID: 10626562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using a spontaneous profile rather than stimulation test makes the KIGS idiopathic growth hormone deficiency model more accessible for clinicians.
    Duchén K; Lindberg A; Kiplok K; Kriström B
    Acta Paediatr; 2017 Sep; 106(9):1481-1486. PubMed ID: 28543706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The growth response to growth hormone (GH) treatment in children with isolated GH deficiency is independent of the presence of the exon 3-minus isoform of the GH receptor.
    Blum WF; Machinis K; Shavrikova EP; Keller A; Stobbe H; Pfaeffle RW; Amselem S
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4171-4. PubMed ID: 16868057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database).
    Ranke MB; Lindberg A; Cowell CT; Wikland KA; Reiter EO; Wilton P; Price DA;
    J Clin Endocrinol Metab; 2003 Jan; 88(1):125-31. PubMed ID: 12519840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study.
    Ranke MB; Guilbaud O; Lindberg A; Cole T
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():82-8; discussion 89. PubMed ID: 8219483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-onset idiopathic growth hormone deficiency within KIGS.
    Ranke MB; Lindberg A;
    Horm Res; 2003; 60(Suppl 1):18-21. PubMed ID: 12955013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables.
    Ranke MB; Lindberg A;
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1229-37. PubMed ID: 20097713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study.
    Ranke MB; Guilbaud O
    Acta Paediatr Scand Suppl; 1991; 379():109-15; discussion 116. PubMed ID: 1815451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database.
    Reiter EO; Price DA; Wilton P; Albertsson-Wikland K; Ranke MB
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2047-54. PubMed ID: 16537676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of prediction models based on data from KIGS as tools to measure responsiveness to growth hormone. Pharmacia International Growth Database.
    Ranke MB; Lindberg A; Chatelain P; Wilton P; Price DA; Albertsson-Wikland K;
    Horm Res; 2001; 55 Suppl 2():44-8. PubMed ID: 11684876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a mathematical model predicting the response to growth hormone treatment in prepubertal children with idiopathic growth hormone deficiency.
    Vosahlo J; Zidek T; Lebl J; Riedl S; Frisch H
    Horm Res; 2004; 61(3):143-7. PubMed ID: 14676463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.